Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Dec 2017 09:00

RNS Number : 0526A
Royal Bank of Scotland Group PLC
21 December 2017
 

21 December 2017

The Royal Bank of Scotland Group plc 

LEI: 2138005O9XJIJN4JPN90

Directorate Changes

The Royal Bank of Scotland Group plc ("RBS") announces today that with effect from 1 January 2018:-

· Sir Sandy Crombie will step down as a non-executive director of RBS, and as Senior Independent Director and Chairman of the Group Performance & Remuneration Committee;

· Robert Gillespie will assume the role of Chairman of the Group Performance & Remuneration Committee;

· Mark Seligman will assume the role of Senior Independent Director and will be appointed as a member of the Group Performance & Remuneration Committee; and

· Dr Lena Wilson, CBE will be appointed as a non-executive director of RBS.

Howard Davies, Chairman of RBS, said:

"Sandy Crombie has made an outstanding contribution to the Board of RBS and we have benefitted greatly from his wisdom and experience. The Board and I will miss Sandy's presence as a much valued colleague and friend, and he leaves RBS with our very best wishes for the future.

I am delighted that Robert Gillespie will be building on Sandy's excellent work as Chairman of the Group Performance & Remuneration Committee, and that Mark Seligman is assuming the pivotal role of Senior Independent Director. Robert and Mark are both ideally suited to these positions, and I know they will have much to contribute. Mark will also join the Group Performance & Remuneration Committee.

Finally, we are very pleased to welcome Dr Lena Wilson as a non-executive director. With her strong public sector and commercial background, I am confident that Lena's appointment will further strengthen the RBS Board's composition and we look forward to welcoming her to the Board."

Lena Wilson has been a non-executive director and member of the audit committee of Intertek Group plc since 2012.

There are no other matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

RBS Media Centre +44 131 523 4205

Notes to Editors

Biographical Details

Dr Lena Wilson, CBE

Lena Wilson was Chief Executive of Scottish Enterprise from November 2009 until October 2017, having previously held the roles of Chief Operating Officer, Chief Executive Officer, Scottish Development International (Scotland's international trade and investment arm) and Senior Director, Customer Relations. Prior to that, Lena was Senior Investment Advisor to The World Bank in Washington DC, advising developing countries on foreign direct investment and private sector development.  Lena has also served as a member of Scotland's Financial Services Advisory Board and as Chair of Scotland's Energy Jobs Taskforce.

Lena has been a non-executive director and member of the audit committee of Intertek Group plc since 2012 and was appointed as a non-executive director of Scottish Power Renewables Limited in November 2017. She is also an ambassador for The Prince & Princess of Wales Hospice (Glasgow) and the Edinburgh Military Tattoo, and served on the Board of the Prince's Scottish Youth Business Trust for 10 years. In June 2015, Dr Wilson received a CBE for her services to economic development in Scotland.

Robert Gillespie

Robert Gillespie joined the RBS Board in December 2013 and is a member of the Group Nominations & Governance Committee, Group Performance and Remuneration Committee, Sustainable Banking Committee and GRG Board Oversight Committee. He is also an independent board director at Ashurst LLP and Chairman of Council at the University of Durham. Robert began his career with Price Waterhouse where he qualified as a chartered accountant. He then moved into banking, joining SG Warburg and specialising in corporate finance, and was appointed as Co-Head and Managing Director of its US investment banking business in 1989. Following the acquisition in 1995 of Warburg by Swiss Bank Corporation (which subsequently merged with UBS), he then held various management roles before being appointed Vice Chairman of UBS Bank. Robert was also seconded to the UK Panel on Takeovers and Mergers as Director General, from 2010 to 2013.

Mark Seligman

Mark Seligman joined the RBS Board in April 2017 and is a member of the Group Nominations & Governance Committee. He has substantial FTSE 100 Board experience and is currently Senior Independent Director of Kingfisher plc, and a non-executive director of Smiths Group plc. Mark previously served as a non-executive Director of BG Group plc and as Deputy Chairman of G4S plc. During his executive career, Mark held various senior roles at Credit Suisse / BZW (including Deputy Chairman, CSFB Europe and Chairman, UK Investment Banking, CSFB); and previously SG Warburg (ultimately as Managing Director, Head of Advisory).  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGIBDDSUDBGRB
Date   Source Headline
17th Mar 20205:24 pmRNSDirectorate Change
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20208:30 amRNSMorgan Stanley European Financials Conference
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
10th Mar 20204:51 pmRNSDirector/PDMR Shareholding
2nd Mar 20202:34 pmRNSDirector/PDMR Shareholding
28th Feb 20204:29 pmRNSCorrection of Dividend Declaration
28th Feb 20201:58 pmRNSTotal Voting Rights and Capital
28th Feb 20207:00 amRNSFiling of Annual Report on Form 20-F with US SEC
27th Feb 20209:55 amRNSBlock Listing Cancellation
24th Feb 202012:40 pmRNSDividend Declaration
20th Feb 20204:10 pmRNSHolding(s) in Company
14th Feb 20203:58 pmRNSRBSG ENTM Publication of Suppl.Prospcts
14th Feb 20207:01 amRNSAnnual Financial Report
14th Feb 20207:00 amRNSFinal Results
31st Jan 20202:12 pmRNSTotal Voting Rights and Capital
30th Jan 20203:57 pmRNSDirector/PDMR Shareholding
16th Jan 20202:08 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Jan 20201:58 pmRNSForm 8.3 - Accesso Technology Group plc
31st Dec 20191:10 pmRNSDirector/PDMR Shareholding
31st Dec 201911:20 amRNSTotal Voting Rights and Capital
30th Dec 20193:02 pmRNSForm 8.3 - Accesso Technology Group plc
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts replacement
19th Dec 20195:40 pmRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20195:47 pmRNS2019 Bank of England stress test results
4th Dec 201912:34 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Dec 20195:34 pmRNSPublication of Suppl.Prospcts
29th Nov 20192:20 pmRNSDirector/PDMR Shareholding
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
29th Nov 201912:01 pmRNSTotal Voting Rights and Capital
27th Nov 201911:56 amRNSDividend Declaration
21st Nov 20196:26 pmRNSPublication of a Prospectus
21st Nov 201910:45 amRNSReduction in Pillar 2A capital requirements
14th Nov 201911:23 amRNSPublication of Final Terms
13th Nov 20193:00 pmRNSForm 8.3 - Accesso Technology Group plc
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
1st Nov 20194:12 pmRNSDirector/PDMR Shareholding
31st Oct 20193:30 pmRNSDirector/PDMR Shareholding
31st Oct 20192:08 pmRNSTotal Voting Rights and Capital
30th Oct 20199:38 amRNSRBSG pricing of US$750mn of Subordinated Notes
25th Oct 20195:22 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:00 amRNSQ3 Interim Management Statement
16th Oct 20192:54 pmRNSForm 8.3 - Accesso Technology Group plc
8th Oct 201911:35 amRNSBlock Listing Six Monthly Return
3rd Oct 20191:08 pmRNSPublication of Final Terms
1st Oct 20195:29 pmRNSDirector/PDMR Shareholding
30th Sep 20193:28 pmRNSTotal Voting Rights
24th Sep 20198:30 amRNSBank of America Merrill Lynch Annual Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.